ACTRN12615001220550招募中未知
Faecal Microbiota Transplantation (FMT) in recurrent or relapsing Clostridium difficile (CDI) in Western Australia, assessment of efficacy and safety
Fiona Stanley Fremantle Hospital Group0 个研究点目标入组 50 人开始时间: 2015年11月9日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Patients aged >18 yr old within the Western Australian Health system
- •Symptoms of diarrhoea (Bristol Stool Scale > 5) with 1 > bowel movements per day above their usual bowel frequency
- •Stool examination is positive for Clostridium difficile toxin PCR
- •Have completed at least two courses of standard antibiotic therapy for Clostridium difficile infection within 6 months of recruitment
排除标准
- •No diarrhoea or gastrointestinal symptoms
- •Negative stool Clostridium difficile toxin PCR
- •Not completed 2 standard courses of antibiotic therapy for clostridium difficile infection within 6 months of recruitment
研究者
相似试验
已完成
1 期
Effect of fecal microbita transplantation in treatment of PCOSPoly-cystic ovary syndrome.Polycystic ovarian syndromeE28.2IRCT20190523043674N1Boushehr University of Medical Sciences15
尚未招募
2 期
Stool transplant for treatment of colitis and crohns diseaseCTRI/2021/03/032131Dayanand Medical College and Hospital
尚未招募
3 期
Fecal Therapy for ColitisCTRI/2021/03/032332Dayanand Medical College and Hospital
招募中
不适用
A study access the efficacy of the stool Transplantation in patients suffering with Minimal hepatic encephalopathy.CTRI/2023/02/050008All India Institute of Medical Sciences
招募中
2 期
Efficacy of Fecal Microbiota Transplantation (FMT) in Irritable Bowel Syndrome (IBS): A Randomized, placebo-controlled, double-blind studyirritable bowel syndromefecal microbiota transplantationtreatment outcomequality of lifeTCTR20230904002Thammasat university45